Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Jean-Claude Horiot
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Concepts & Ideas
Procedures
Disorders
Sign-in to see full Profile
Network (preview)
25
Barillot, Isabelle
22
Van den Bogaert, Walter
20
Maingon, Philippe
19
Bartelink, Harry
17
Pierart, Marianne
14
Collette, Laurence
13
Struikmans, Henk
13
Poortmans, Philip
11
Truc, Gilles
10
van der Schueren, E
9
Jager, Jos
8
Van Glabbeke, Martine
8
Rozan, R
7
Fourquet, Alain
6
D'Hombres, A
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Jean-Claude Horiot (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Jones Heather A; Antonini Ninja; Hart Augustinus A M; Peterse Johannes L; Horiot Jean-Claude; Collin Françoise; Poortmans Philip M; Oei S Bing; Collette Laurence; Struikmans Henk; Van den Bogaert Walter F; Fourquet Alain; Jager Jos J; Schinagl Dominic A X; Wárlám-Rodenhuis Carla C; Bartelink Harry
Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(30):4939-47.
-
2009: Al Uwini Shafak; Antonini Ninja; Poortmans Philip M; Boersma Liesbeth; Hurkmans Coen; Leer Jan Willem; Horiot Jean-Claude; Struikmans Henk; Bartelink Harry
The influence of the use of CT-planning on the irradiated boost volume in breast conserving treatment.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;93(1):87-93.
-
2009: Poortmans Philip M; Collette Laurence; Horiot Jean-Claude; Van den Bogaert Walter F; Fourquet Alain; Kuten Abraham; Noordijk Evert M; Hoogenraad Willem; Mirimanoff René-Olivier; Pierart Marianne; Van Limbergen Erik; Bartelink Harry;
Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;90(1):80-5.
-
2008: Vautravers Claire; Rat Patrick; Cercueil Jean-Pierre; Moreau Thibault; Horiot Jean-Claude; Chauffert Bruno
Hepatocellular carcinoma presenting as paraneoplastic myasthenia gravis.
European journal of internal medicine 2008;19(8):e86-7.
-
2008: Collette Sandra; Collette Laurence; Budiharto Tom; Horiot Jean-Claude; Poortmans Philip M; Struikmans Henk; Van den Bogaert Walter; Fourquet Alain; Jager Jos J; Hoogenraad Willem; Mueller Rolf-Peter; Kurtz John; Morgan David A L; Dubois Jean-Bernard; Salamon Emile; Mirimanoff Rene; Bolla Michel; Van der Hulst Marleen; Wárlám-Rodenhuis Carla C; Bartelink Harry;
Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'.
European journal of cancer (Oxford, England : 1990) 2008;44(17):2587-99.
-
2007: Bartelink Harry; Horiot Jean-Claude; Poortmans Philip M; Struikmans Henk; Van den Bogaert Walter; Fourquet Alain; Jager Jos J; Hoogenraad Willem J; Oei S Bing; Wárlám-Rodenhuis Carla C; Pierart Marianne; Collette Laurence
Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(22):3259-65.
-
2007: Horiot Jean-Claude
At last--progress in the assessment of the adverse effects of cancer treatments.
The lancet oncology 2007;8(7):568-70.
-
2007: Horiot Jean-Claude
Radiation therapy and the geriatric oncology patient.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(14):1930-5.
-
2007: Antonini Ninja; Jones Heather; Horiot Jean Claude; Poortmans Philip; Struikmans Henk; Van den Bogaert Walter; Barillot Isabelle; Fourquet Alain; Jager Jos; Hoogenraad Willem; Collette Laurence; Pierart Marianne; Hart Guus; Bartelink Harry
Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2007;82(3):265-71.
-
2006: Bourhis Jean; Overgaard Jens; Audry Hélène; Ang Kian K; Saunders Michele; Bernier Jacques; Horiot Jean-Claude; Le Maître Aurélie; Pajak Thomas F; Poulsen Michael G; O'Sullivan Brian; Dobrowsky Werner; Hliniak Andrzej; Skladowski Krzysztof; Hay John H; Pinto Luiz H J; Fallai Carlo; Fu Karen K; Sylvester Richard; Pignon Jean-Pierre;
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.
Lancet 2006;368(9538):843-54.
-
2006: Horiot Jean-Claude
Perspectives in gynecologic oncology -- Third European Conference.
IDrugs : the investigational drugs journal 2006;9(3):154-6.
-
2005: Poortmans Philip M P; Ataman Fatma; Davis Jacques Bernard; Bartelink Harry; Horiot Jean-Claude; Pierart Marianne; Collette Laurence; Van Tienhoven Geertjan
Quality assurance in the EORTC phase III randomised 'boost vs. no boost' trial for breast conserving therapy: comparison of the results of two individual case reviews performed early and late during the accrual period.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2005;76(3):278-84.
-
2005: Poortmans P M; Davis J B; Ataman F; Bernier J; Horiot J-C;
The quality assurance programme of the Radiotherapy Group of the European Organisation for Research and Treatment of Cancer: past, present and future.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2005;31(6):667-74.
-
2005: Horiot Jean-Claude
Antiemetic therapy in cancer: an update.
Expert opinion on pharmacotherapy 2005;6(10):1713-23.
-
2004: Horiot Jean-Claude
Prophylaxis versus treatment: is there a better way to manage radiotherapy-induced nausea and vomiting?
International journal of radiation oncology, biology, physics 2004;60(4):1018-25.
-
2004: Thariat J; Bruchon Y; Bonnetain F; Barillot I; Truc G; Peignaux K; Horiot J C; Maingon P
Conservative treatment of early glottic carcinomas with exclusive radiotherapy.
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 2004;8(5):288-96.
-
2004: Horiot Jean-Claude
Blueprint for the control of radiation-induced nausea and vomiting. Discussion.
Acta oncologica (Stockholm, Sweden) 2004;43 Suppl 15():23-4.
-
2004: Horiot Jean-Claude
Blueprint for the control of radiation-induced nausea and vomiting. Introduction.
Acta oncologica (Stockholm, Sweden) 2004;43 Suppl 15():3-4.
-
2004: Poortmans Philip; Bartelink Harry; Horiot Jean-Claude; Struikmans Henk; Van den Bogaert Walter; Fourquet Alain; Jager Jos; Hoogenraad Willem; Rodrigus Patrick; Wárlám-Rodenhuis Carla; Collette Laurence; Pierart Marianne;
The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2004;72(1):25-33.
-
2004: Horiot J-C; Aapro M
Treatment implications for radiation-induced nausea and vomiting in specific patient groups.
European journal of cancer (Oxford, England : 1990) 2004;40(7):979-87.
-
2004: Ysebaert Loïc; Truc Gilles; Dalac Sophie; Lambert Daniel; Petrella Tony; Barillot Isabelle; Naudy Suzanne; Horiot Jean-Claude; Maingon Philippe
Ultimate results of radiation therapy for T1-T2 mycosis fungoides (including reirradiation).
International journal of radiation oncology, biology, physics 2004;58(4):1128-34.
-
2004: Coatmeur Olivier; Truc Gilles; Barillot Isabelle; Horiot Jean-Claude; Maingon Philippe
Treatment of T1-T2 rectal tumors by contact therapy and interstitial brachytherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2004;70(2):177-82.
-
2004: Horiot Jean Claude; Barillot Isabelle; Maingon Philippe; Truc Gilles
Endometrial carcinomas: which radiotherapy for which patient?
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2004;9(1):5-12.
-
2003: Dussère Pierre; Michiels Robert; Horiot Jean-Claude
[Ferdinand Cabanne (1920-2003)]
Bulletin du cancer 2003;90(11):933-4.
-
2003: Vrieling C; Collette L; Fourquet A; Hoogenraad W J; Horiot J-C; Jager J J; Bing Oei S; Peterse H L; Pierart M; Poortmans P M; Struikmans H; Van den Bogaert W; Bartelink H;
Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients?
European journal of cancer (Oxford, England : 1990) 2003;39(7):932-44.
-
2003: Kouloulias V E; Poortmans P M; Bernier J; Horiot J C; Johansson K A; Davis B; Godson F; Garavaglia G; Pierart M; van der Schueren E
The Quality Assurance programme of the Radiotherapy Group of the European Organization for Research and Treatment of Cancer (EORTC): a critical appraisal of 20 years of continuous efforts.
European journal of cancer (Oxford, England : 1990) 2003;39(4):430-7.
-
2003: Khalil Azza A; Bentzen Søren M; Bernier Jacques; Saunders Michele I; Horiot Jean-Claude; Van Den Bogaert Walter; Cummings Bernard J; Dische Stanley
Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas.
International journal of radiation oncology, biology, physics 2003;55(3):568-75.
-
2002: Bartelink H; Van den Bogaert W; Horiot J-C; Jager J; van Glabbeke M
Concomitant cisplatin and radiotherapy in a conventional and modified fractionation schedule in locally advanced head and neck cancer: a randomised phase II EORTC trial.
European journal of cancer (Oxford, England : 1990) 2002;38(5):667-73.
-
2002: Bernier J; Horiot J C; Poortmans P
Quality assurance in radiotherapy: from radiation physics to patient- and trial-oriented control procedures.
European journal of cancer (Oxford, England : 1990) 2002;38 Suppl 4():S155-8.
-
2002: Horiot Jean-Claude
FECS 20th Birthday--a survivor speaks.
European journal of cancer (Oxford, England : 1990) 2002;38(1):8-10.
-
2001: Bartelink H; Horiot J C; Poortmans P; Struikmans H; Van den Bogaert W; Barillot I; Fourquet A; Borger J; Jager J; Hoogenraad W; Collette L; Pierart M;
Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.
The New England journal of medicine 2001;345(19):1378-87.
-
2001: Bosset J F; Horiot J C; Hamers H P; Cionini L; Bartelink H; Caspers R; Untereiner M; Ciambelloti E; Pierart M; Van Glabbeke M
Postoperative pelvic radiotherapy with or without elective irradiation of para-aortic nodes and liver in rectal cancer patients. A controlled clinical trial of the EORTC Radiotherapy Group.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2001;61(1):7-13.
-
2001: Cottin Y; Zeller M; Allouch P; Maingon P; Barillot I; Busseuil D; Naudy S; Horiot J C; Rochette L; Wolf J E
[Secondary effects of brachytherapy in the treatment of coronary restenosis]
Archives des maladies du coeur et des vaisseaux 2001;94(3):218-22.
-
2000: Truc G; Horiot J C; Maingon P; Barillot I
[Epidermoid cancer of the oropharynx]
Bulletin du cancer 2000;Suppl 5():9-19.
-
2000: Barillot I; Maingon P; Truc G; Steyer B; Naudy S; Horiot J C
[Assessment of the use of electronic portal imaging]
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 2000;4 Suppl 1():25s-30s.
-
2000: Barillot I; Horiot J C; Maingon P; Truc G; Chaplain G; Comte J; Brenier J P
Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas: baseline results to compare new strategies.
International journal of radiation oncology, biology, physics 2000;48(1):189-200.
-
2000: Horiot J C; Lipinski F; Schraub S; Maulard-Durdux C; Bensadoun R J; Ardiet J M; Bolla M; Coscas Y; Baillet F; Coche-Dequéant B; Urbajtel M; Montbarbon X; Bourdin S; Wibault M; Alfonsi M; Calais G; Desprez P; Pene F; Lapeyre M; Vinke J; Maral J
Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2000;55(3):233-9.
-
2000: Bernier J; Denekamp J; Rojas A; Minatel E; Horiot J; Hamers H; Antognoni P; Dahl O; Richaud P; van Glabbeke M; Piérart M
ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative group of radiotherapy of the european organization for research and treatment of cancer (EORTC).
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2000;55(2):111-9.
-
2000: Barillot I; Maingon P; Truc G; Horiot J C
[Complications of treatments of invasive cancers of the uterine cervix with intact uterus: results and prevention]
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 2000;4(2):147-58.
-
2000: Bentzen S M; Bernier J; Davis J B; Horiot J C; Garavaglia G; Chavaudra J; Johansson K A; Bolla M
Clinical impact of dosimetry quality assurance programmes assessed by radiobiological modelling of data from the thermoluminescent dosimetry study of the European Organization for Research and Treatment of Cancer.
European journal of cancer (Oxford, England : 1990) 2000;36(5):615-20.
-
2000: Barillot I; Maingon P; Truc G; D'Hombres A; Steyer B; Naudy S; Horiot J C
[Evolution of the use of the portal imaging device: prospective study over three years]
Cancer radiothérapie : journal de la Société française de radiothérapie oncologique 2000;4(1):40-53.
-
2000: Maingon P; Truc G; Dalac S; Barillot I; Lambert D; Petrella T; Naudy S; Horiot J C
Radiotherapy of advanced mycosis fungoides: indications and results of total skin electron beam and photon beam irradiation.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2000;54(1):73-8.
-
2000: Bosset J F; Magnin V; Maingon P; Mantion G; Pelissier E P; Mercier M; Chaillard G; Horiot J C
Preoperative radiochemotherapy in rectal cancer: long-term results of a phase II trial.
International journal of radiation oncology, biology, physics 2000;46(2):323-7.
-
2000: Maingon P; d'Hombres A; Truc G; Barillot I; Michiels C; Bedenne L; Horiot J C
High dose rate brachytherapy for superficial cancer of the esophagus.
International journal of radiation oncology, biology, physics 2000;46(1):71-6.
-
1999: Meunier F; Horiot J C
EORTC scientific strategy meeting 25-26 March 1999.
European journal of cancer (Oxford, England : 1990) 1999;35(10):1423-30.
-
1999: Vrieling C; Collette L; Fourquet A; Hoogenraad W J; Horiot J C; Jager J J; Pierart M; Poortmans P M; Struikmans H; Van der Hulst M; Van der Schueren E; Bartelink H
The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer.
International journal of radiation oncology, biology, physics 1999;45(3):677-85.
-
1999: Vrieling C; Collette L; Bartelink E; Borger J H; Brenninkmeyer S J; Horiot J C; Pierart M; Poortmans P M; Struikmans H; Van der Schueren E; Van Dongen J A; Van Limbergen E; Bartelink H
Validation of the methods of cosmetic assessment after breast-conserving therapy in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer.
International journal of radiation oncology, biology, physics 1999;45(3):667-76.
-
1999: Bernier J; Denekamp J; Rojas A; Trovò M; Horiot J C; Hamers H; Antognoni P; Dahl O; Richaud P; Kaanders J; van Glabbeke M; Piérart M
ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by the EORTC.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1999;52(2):149-56.
-
1999: Begg A C; Haustermans K; Hart A A; Dische S; Saunders M; Zackrisson B; Gustaffson H; Coucke P; Paschoud N; Hoyer M; Overgaard J; Antognoni P; Richetti A; Bourhis J; Bartelink H; Horiot J C; Corvo R; Giaretti W; Awwad H; Shouman T; Jouffroy T; Maciorowski Z; Dobrowsky W; Struikmans H; Wilson G D
The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1999;50(1):13-23.
-
1999: Barillot I; Horiot J C
[Prevention of caries and osteoradionecrosis in patients irradiated in oncology. Critical review]
Revue belge de médecine dentaire. Belgisch tijdschrift voor tandheelkunde 1999;54(3):205-7.
-
1999: Ptaszynski A M; Van den Bogaert W; Horiot J C; Poortmans P; Fourquet A; Struikmans H; Bartelink H; Pierart M; Collette L; van der Schueren E
Radiation dose homogeneity in an EORTC multicenter trial on breast irradiation.
Acta oncologica (Stockholm, Sweden) 1999;38 Suppl 13():19-27.
-
1998: Maingon P; Arnould L; Magnin V; Collin F; Belichard C; Fraisse J; Barillot I; d'Hombres A; Bône-Lepinoy M C; Padeano M M; Douvier S; Cuisenier J; Horiot J C
Preoperative radiotherapy and surgery for endometrial carcinoma: prognostic significance of the sterilization of the specimen.
International journal of radiation oncology, biology, physics 1998;41(3):551-7.
-
1998: Maingon P; Guerif S; Darsouni R; Salas S; Barillot I; d'Hombres A; Bône-Lepinoy M C; Fraisse J; Horiot J C
Conservative management of rectal adenocarcinoma by radiotherapy.
International journal of radiation oncology, biology, physics 1998;40(5):1077-85.
-
1997: Horiot J C; Bontemps P; van den Bogaert W; Le Fur R; van den Weijngaert D; Bolla M; Bernier J; Lusinchi A; Stuschke M; Lopez-Torrecilla J; Begg A C; Pierart M; Collette L
Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1997;44(2):111-21.
-
1997: Barillot I; Bone-Lepinoy M C; Horiot J C; Maingon P; Chaplain G; D'Hombres A; Comte J
Organ preservation in cervix cancer.
Rays 1997;22(3):410-6.
-
1997: Barillot I; Horiot J C; Pigneux J; Schraub S; Pourquier H; Daly N; Bolla M; Rozan R
Carcinoma of the intact uterine cervix treated with radiotherapy alone: a French cooperative study: update and multivariate analysis of prognostics factors.
International journal of radiation oncology, biology, physics 1997;38(5):969-78.
-
1997: Pignon T; Horiot J C; Bolla M; van Poppel H; Bartelink H; Roelofsen F; Pene F; Gerard A; Einhorn N; Nguyen T D; Vanglabbeke M; Scalliet P
Age is not a limiting factor for radical radiotherapy in pelvic malignancies.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1997;42(2):107-20.
-
1996: Karim A B; Maat B; Hatlevoll R; Menten J; Rutten E H; Thomas D G; Mascarenhas F; Horiot J C; Parvinen L M; van Reijn M; Jager J J; Fabrini M G; van Alphen A M; Hamers H P; Gaspar L; Noordman E; Pierart M; van Glabbeke M
A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844.
International journal of radiation oncology, biology, physics 1996;36(3):549-56.
-
1996: Bosset J F; Pavy J J; Magnin V; Hamers H P; Horiot J C
Palliative endoscopic therapy of rectal carcinoma.
European journal of cancer (Oxford, England : 1990) 1996;32A(11):2031-2.
-
1996: Maingon P; Horiot J C; Fraisse J; Salas S; Collin F; Bône-Lepinoy M C; Barillot I; Douvier S; Padéano M M; Cuisenier J
Preoperative radiotherapy in stage I/II endometrial adenocarcinoma.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1996;39(3):201-8.
-
1996: Bernier J; Horiot J C; Bartelink H; Johansson K A; Cionini L; Gonzalèz Gonzalèz D; Hamers H; van den Bogaert W
Profile of radiotherapy departments contributing to the Cooperative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer.
International journal of radiation oncology, biology, physics 1996;34(4):953-60.
-
1996: Barillot I; Horiot J C; Maingon P; Bône-Lepinoy M C; D'Hombres A; Comte J
[Locally advanced carcinoma of the cervix (distal II, Barrel-shaped and III) treated by irradiation alone: impact of individual treatment planning on results, sequelae and complications]
Bulletin du cancer. Radiothérapie : journal de la Société française du cancer : organe de la société française de radiothérapie oncologique 1996;83(4):364-9.
-
1996: Horiot J C; Bontemps P; Begg A C; Le Fur R; Van den Bogaert W; Bolla M; N'Guyen T; Van den Weijngaert D; Bernier J; Lusinchi A; Stuschke D; Lopez Torrecilla D; Jancar B; Collette L; Van Glabbeke M; Pierart M
[Hyperfractionated and accelerated radiotherapy in head and neck cancers: results of the EORTC trials and impact on clinical practice]
Bulletin du cancer. Radiothérapie : journal de la Société française du cancer : organe de la société française de radiothérapie oncologique 1996;83(4):314-20.
-
1996: Bosset J F; Pelissier E P; Mantion G; Horiot J C; Pavy J J
[Concomitant preoperative radiochemotherapy for rectal cancers]
Annales de chirurgie 1996;50(4):302-10; discussion 311.
-
1995: Horiot J C; Bosset J F; Maingon P
Improvement of the curative management of rectal cancers by better use of radiotherapy.
European journal of cancer (Oxford, England : 1990) 1995;31A(7-8):1382-4.
-
1995: Van den Bogaert W; van der Schueren E; Horiot J C; De Vilhena M; Schraub S; Svoboda V; Arcangeli G; de Pauw M; Van Glabbeke M
The EORTC randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer: long-term results and side effects.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1995;35(2):91-9.
-
1995: Van den Bogaert W; van der Schueren E; Horiot J C; De Vilhena M; Schraub S; Svoboda V; Arcangeli G; de Pauw M; van Glabbeke M
The EORTC randomized trial on three fractions per day and misonidazole in advanced head and neck cancer: prognostic factors.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1995;35(2):100-6.
-
1995: Bosset J F; Pelissier E; Mantion G; Pavy J J; Horiot J C; Hamers H P; Bartelink H
In response to McLean and Duncan.
International journal of radiation oncology, biology, physics 1995;31(4):1024-5.
-
1994: Horiot J C; Maingon P; Barillot I
Radiotherapy for head and neck cancers including chemoradiotherapy.
Current opinion in oncology 1994;6(3):272-6.
-
1994: Bosset J F; Pelissier E P; Maniion G; Pavy J J; Horiot J C; Hamers H P; Bartelink H
Plea for a preoperative adjuvant approach in the management of rectal cancer.
International journal of radiation oncology, biology, physics 1994;29(1):205-8; discussion 215-6.
-
1994: Barillot I; Horiot J C; Maingon P; Bone-Lepinoy M C; Vaillant D; Feutray S
Maximum and mean bladder dose defined from ultrasonography. Comparison with the ICRU reference in gynaecological brachytherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1994;30(3):231-8.
-
1994: Horiot J C; Begg A C; Le Fur R; Schraub S; van den Bogaert W; van Glabbeke M; Pierart M
Present status of EORTC trials of hyperfractionated and accelerated radiotherapy on head and neck carcinoma.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1994;134():111-9.
-
1994: Ptaszynski A; Van den Bogaert W; Van Glabbeke M; Pierart M; Bartelink H; Horiot J C; Fourquet A; Struikmans H; Hamers H; Müller R P
Patient population analysis in EORTC trial 22881/10882 on the role of a booster dose in breast-conserving therapy.
European journal of cancer (Oxford, England : 1990) 1994;30A(14):2073-81.
-
1994: Barillot I; Horiot J C; Pigneux J; Schraub S; Rozan R; Daly N; Bolla M; Pourquier H
[Carcinomas of the uterine cervix in young women: study of the French cooperative group]
Bulletin du cancer. Radiothérapie : journal de la Société française du cancer : organe de la société française de radiothérapie oncologique 1994;81(4):432-6.
-
1993: Bosset J F; Pavy J J; Hamers H P; Horiot J C; Fabri M C; Rougier P; Eschwege F; Schraub S
Determination of the optimal dose of 5-fluorouracil when combined with low dose D,L-leucovorin and irradiation in rectal cancer: results of three consecutive phase II studies. EORTC Radiotherapy Group.
European journal of cancer (Oxford, England : 1990) 1993;29A(10):1406-10.
-
1993: Barillot I; Horiot J C; Cuisenier J; Pigneux J; Schraub S; Rozan R; Pourquier H; Daly N; Vrousos C; Keiling R
Carcinoma of the cervical stump: a review of 213 cases.
European journal of cancer (Oxford, England : 1990) 1993;29A(9):1231-6.
-
1992: Horiot J C; Le Fur R; N'Guyen T; Chenal C; Schraub S; Alfonsi S; Gardani G; Van Den Bogaert W; Danczak S; Bolla M
Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1992;25(4):231-41.
-
1992: Schraub S; Sun X S; Maingon P; Horiot J C; Daly N; Keiling R; Pigneux J; Pourquier H; Rozan R; Vrousos C
Cervical and vaginal cancer associated with pessary use.
Cancer 1992;69(10):2505-9.
-
1990: Horiot J C; Roth S L; Calais G; Nabid A; Bone-Lepinoy M C; Loiseau D
The Dijon clinical staging system for early rectal carcinomas amenable to intracavitary treatment techniques.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1990;18(4):329-37.
-
1990: Douvier S; Cuisenier J; Nabholtz J M; Perez A; Bréchet E; Horiot J C
[Stage 1 and 2 cancers of the endometrium. Value of the combination of pelvic radiotherapy and curietherapy followed by a total hysterectomy without lymph node removal]
Journal de gynécologie, obstétrique et biologie de la reproduction 1990;19(1):107-12.
-
1990: Horiot J C; Le Fur R; N'Guyen T; Chenal C; Schraub S; Alfonsi S; Gardani G; Van den Bogaert W; Danczak S; Bolla M
Hyperfractionated compared with conventional radiotherapy in oropharyngeal carcinoma: an EORTC randomized trial.
European journal of cancer (Oxford, England : 1990) 1990;26(7):779-80.
-
1989: Roth S L; Horiot J C; Calais G; Nabid A; Bone-Lepinoy M C
Prognostic factors in limited rectal cancer treated with intracavitary irradiation.
International journal of radiation oncology, biology, physics 1989;16(6):1445-51.
-
1988: Horiot J C; Pigneux J; Pourquier H; Schraub S; Achille E; Keiling R; Combes P; Rozan R; Vrousos C; Daly N
Radiotherapy alone in carcinoma of the intact uterine cervix according to G. H. Fletcher guidelines: a French cooperative study of 1383 cases.
International journal of radiation oncology, biology, physics 1988;14(4):605-11.
-
1988: Roth S L; Horiot J C; Calais G; Nabid A; Bone M C
Results of endocavitary irradiation of early rectal tumors.
Acta oncologica (Stockholm, Sweden) 1988;27(6b):825-7.
-
1988: Nabholtz J M; Friedman S; Bastien H; Cuisenier J; Horiot J C; Guerrin J
A clinico-pathological and prognostic analysis of non-Hodgkin lymphoma. A study of 203 patients.
Acta oncologica (Stockholm, Sweden) 1988;27(5):489-95.
-
1987: Pourquier H; Delard R; Achille E; Daly N J; Horiot J C; Keiling R; Pigneux J; Rozan R; Schraub S; Vrousos C
A quantified approach to the analysis and prevention of urinary complications in radiotherapeutic treatment of cancer of the cervix.
International journal of radiation oncology, biology, physics 1987;13(7):1025-33.
-
1987: Pourquier H; Pigneux J; Horiot J C; Schraub S; Combes P; Kerling R; Vrousos C; Rozan R; Achille E; Daly N
[Long-term results of the treatment with physical agents exclusively in a series of cancers of the uterine cervix. Cooperative study of 1,383 cases]
Journal de gynécologie, obstétrique et biologie de la reproduction 1987;16(7):935-42.
-
1986: Horiot J C; Johansson K A; Gonzalez D G; van der Schueren E; van den Bogaert W; Notter G
Quality assurance control in the EORTC cooperative group of radiotherapy. 1. Assessment of radiotherapy staff and equipment. European Organization for Research and Treatment of Cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1986;6(4):275-84.
-
1986: van den Bogaert W; van der Schueren E; Horiot J C; Chaplain G; Devilhena M; Raposo S; Leonor J; Schraub S; Chenal C; Barthelme E
Early results of the EORTC randomized clinical trial on multiple fractions per day (MFD) and misonidazole in advanced head and neck cancer.
International journal of radiation oncology, biology, physics 1986;12(4):587-91.
-
1985: Combes P F; Daly N J; Horiot J C; Achille E; Keiling R; Pigneux J; Pourquier H; Rozan R; Schraub S; Vrousos C
Results of radiotherapy alone in 581 patients with Stage II carcinoma of the uterine cervix.
International journal of radiation oncology, biology, physics 1985;11(3):463-71.
-
1985: Van den Bogaert W; van der Schueren E; Van Tongelen C; Horiot J C; Chaplain G; Arcangeli G; Gonzalez D; Svoboda V
Late results of multiple fractions per day (MFD) with misonidazole in advanced cancer of the head and neck. A pilot study of the EORTC radiotherapy group.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1985;3(2):139-44.
-
1984: Horiot J C; Bone M C; Bain Y; Ramadier J; Chaplain G
[Prevention of dental caries after radiotherapy: fluoridated dental gel or toothpaste with high fluoride content: a controlled therapeutic trial]
L' Information dentaire 1984;66(37):3729-35.
-
1984: Bransfield D D; Horiot J C; Abitbol A
A medical chart review for information about sexual functioning in cervical carcinoma.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1984;1(4):317-23.
-
1983: Horiot J C; Schraub S; Bone M C; Bain Y; Ramadier J; Chaplain G; Nabid N; Thevenot B; Bransfield D
Dental preservation in patients irradiated for head and neck tumours: A 10-year experience with topical fluoride and a randomized trial between two fluoridation methods.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1983;1(1):77-82.
-
1982: Van den Bogaert W; van der Schueren E; Horiot J C; Chaplain G; Arcangeli G; Gonzalez D; Svoboda V
The feasibility of high-dose multiple daily fractionation and its combination with anoxic cell sensitizers in the treatment of head and neck cancer. A pilot study of the Radiotherapy Group of the EORTC (European Organisation for Research on Treatment of Cancer).
International journal of radiation oncology, biology, physics 1982;8(10):1649-55.
Sign-in to see more
